|
⚲
|
| Keyboard |
| Usman Nassim
✚
|
|
|---|---|
| CIK # | 0001206872 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001206872] | |
| 4 | [0001206872] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Usman Nassim | |
| GYRE Therapeutics Inc | |
| Principia Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-06-28 | Sell | 3,452 | $12.00 | 41,424 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-06-28 | Option exercise | 3,452 | $6.93 | 23,922 |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-06-28 | Option exercise | 3,452 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-05-01 | Sell | 14,900 | $13.86 | 206,514 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-05-01 | Sell | 100 | $15.63 | 1,563 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-05-01 | Sell | 5,000 | $14.90 | 74,500 |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-05-01 | Option exercise | 20,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-05-01 | Option exercise | 20,000 | $6.93 | 138,600 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-04-01 | Sell | 20,000 | $16.15 | 323,000 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-04-01 | Option exercise | 20,000 | $6.93 | 138,600 |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Option exercise | 20,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2024-03-15 | Option exercise | 20,000 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-03-15 | Option exercise | 20,000 | $6.93 | 138,600 |
|
GYRE Therapeutics Inc GYRE
Common Stock
|
2024-03-15 | Sell | 20,000 | $17.26 | 345,200 |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Grant | 341,652 | $0.00 | |
|
GYRE Therapeutics Inc GYRE
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Grant | 1,866 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Series Y Preferred Stock
|
2023-08-31 | Disposed to issuer | 1.17 | ||
|
GYRE Therapeutics Inc CBIO
Series Y Preferred Stock
|
2023-08-31 | Disposed to issuer | 24.54 | ||
|
GYRE Therapeutics Inc CBIO
Series Y Preferred Stock
|
2023-08-31 | Disposed to issuer | 8.46 | ||
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2022-08-09 | Buy | 3,250 | $0.47 | 1,528 |
| showing 20 of 56 most recent transactions | |||||